Join the club for FREE to access the whole archive and other member benefits.

Darius Widera

Associate Professor, University of Reading

Dr Widera is a Professor of Stem Cell Biology and Regenerative Medicine at the University of Reading. His areas of expertise are adult stem cells, expansion of stem cells for their clinical use, and the role of inflammation in health and disease.

Areas of interest

  • Mesenchymal Stromal/Stem Cells
  • Neural Crest-Derived Stem Cells
  • Neural Stem Cells
  • Cancer Stem Cells
  • 3D cell culture
  • Extracellular vesicle biology
  • Toll-like Receptor 4 Signalling in Health and Disease
  • NF-kappaB Signalling


External Roles:

  • Academic Editor, Stem Cells International
  • Associate Editor, Frontiers in Stem Cell Research (Section of Frontiers in Genetics)
  • Scientific Advisory Member, Argon Llt, Germany
  • MRes Biomedical Sciences and Translational Medicine

Visit website: https://www.reading.ac.uk/pharmacy/about/staff/d-widera.aspx

 dariuswidera

 Darius_Widera

See also: Academia University of Reading - Public university in Reading, England

Details last updated 24-Jun-2020

Darius Widera News

Darius Widera warns of rogue stem cell therapy clinics

Darius Widera warns of rogue stem cell therapy clinics

The Conversation (UK) - 14-Jul-2023

Unregulated clinics worldwide are offering unproven, dangerous treatments, exploiting regulatory loopholes and misleading desperate patients

Leprosy bacteria may hold the secret to safely repairing and regenerating the body

Leprosy bacteria may hold the secret to safely repairing and regenerating the body

BBC - 16-Nov-2022

Biological alchemy by leprosy bacteria-converts one type of bodily tissue into another

New cancer drug shrinks tumour in phase 1 trial

New cancer drug shrinks tumour in phase 1 trial

BBC - 23-Jun-2020

Indeed a new precision approach sparing healthy cells

Articles written by Darius Widera

Darius Widera warns of rogue stem cell therapy clinics

Darius Widera warns of rogue stem cell therapy clinics

The Conversation (UK) - 14-Jul-2023

Unregulated clinics worldwide are offering unproven, dangerous treatments, exploiting regulatory loopholes and misleading desperate patients